CORMEDIX INC. Preferred Stock, Value, Issued
CORMEDIX INC. (CRMD) had Preferred Stock, Value, Issued of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-08-13
- 2026-06-30: Preferred Stock, Value, Issued $0.00.
- 2026-03-31: Preferred Stock, Value, Issued $0.00.
- 2025-12-31: Preferred Stock, Value, Issued $0.00.
- 2025-09-30: Preferred Stock, Value, Issued $92.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-13 |
| 2025-09-30 | $92.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $92.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $92.00 10-Q · filed 2025-05-06 |
| 2024-12-31 | $137.00 10-Q · filed 2025-11-12 |
| 2024-09-30 | $182.00 10-Q · filed 2024-10-30 |
| 2024-06-30 | $182.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $182.00 10-Q · filed 2024-05-09 |
| 2023-12-31 | $182.00 10-K · filed 2025-03-25 |
| 2023-09-30 | $182.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $182.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $182.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $182.00 10-K · filed 2024-03-12 |
| 2022-09-30 | $182.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $182.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $182.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $182.00 10-K · filed 2023-03-30 |
| 2021-09-30 | $182.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $182.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $182.00 10-Q · filed 2021-05-13 |
| 2020-12-31 | $242.00 10-K · filed 2022-03-29 |
| 2020-09-30 | $242.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $242.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $242.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $242.00 10-K · filed 2021-03-30 |
| 2019-09-30 | $244.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $370.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $370.00 10-Q · filed 2019-05-13 |
| 2018-12-31 | $420.00 10-K · filed 2020-03-16 |
| 2018-09-30 | $420.00 10-Q · filed 2018-11-14 |
| 2018-06-30 | $420.00 10-Q · filed 2018-08-14 |
| 2018-03-31 | $420.00 10-Q · filed 2018-05-15 |
| 2017-12-31 | $420.00 10-K · filed 2019-05-29 |
| 2017-09-30 | $418.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $443.00 10-Q · filed 2017-08-09 |
| 2017-03-31 | $443.00 10-Q · filed 2017-05-10 |
| 2016-12-31 | $450.00 10-K · filed 2018-03-19 |
| 2016-09-30 | $450.00 10-Q · filed 2016-11-09 |
| 2016-06-30 | $450.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $450.00 10-Q · filed 2016-05-10 |
| 2015-12-31 | $450.00 10-K · filed 2017-03-16 |
| 2015-09-30 | $450.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $450.00 10-Q · filed 2015-08-06 |
| 2015-03-31 | $450.00 10-Q · filed 2015-05-07 |
| 2014-12-31 | $950.00 10-K · filed 2016-03-15 |
| 2014-09-30 | $955.00 10-Q · filed 2014-11-13 |
| 2014-06-30 | $917.00 10-Q · filed 2014-08-14 |
| 2014-03-31 | $917.00 10-Q · filed 2014-05-15 |
| 2013-12-31 | $857.00 10-K · filed 2015-03-12 |
| 2013-09-30 | $455.00 10-Q/A · filed 2014-03-04 |
| 2013-06-30 | $287.00 10-Q/A · filed 2014-03-04 |
| 2013-03-31 | $287.00 10-Q/A · filed 2014-03-04 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |